ICMR nod for Bengaluru kit that tests for COVID-19 in 1 hour

Read more

April 07, 2020, Deccan Herald

ICMR approves TB machines for Covid-19 testing

Read more

April 04, 2020, The Hindu Business Line

Motilal Oswal PE fund to invest up to Rs 240 crore in Molbio Diagnostics

Read more

March 04, 2020, Economic Times

WHO has announced endorsement of our TB test 'Truenat' for global uptake as a replacement of smear microscopy!

Read more

Januray 15, 2020

Rapid Communication:Molecular assays as initial tests for the diagnosis of tuberculosis and rifampicin resistance

January, 2020

Press coverage of WHO endorsement of our TB test 'Truenat'

January 15,16 2020

Bigteclabs has been certified by CDG Inspection Ltd for BeagleZ product

September 30, 2019

Molbio Diagnostics has recieved Licence to Manufacture for Sale or for Distribution of Class C or Class D medical device

September 12, 2019

Molbio Diagnostics Collaborating with Uruguay

August 08, 2019

Maharashtra: One lakh TB testing kits okayed for better detection

Read more

August 06, 2019, Times Of India

Bigteclabs has been certified by ISO

July 22, 2019

Bigtec Labs, we will continue to build and push the boundaries of medical diagnosis

Read more

July 13, 2019

Health Innovation Exchange Launch Event,
Geneva, 21-23 May 2019

QuantuMDx Group Limited & Molbio Diagnostics announce a MoU

December 12, 2018

Andhra Pradesh Truenat Project

October 02, 2018

Truelab Uno Dx launch in Andhra Pradesh

Truelab Uno Dx launched in Andhra Pradesh by Chief Minister as part of the “AP Tuberculosis Control Program". The Truelab Uno Dx is available across 225 DMC's of AP. Enabling faster and more precise diagnosis of Tuberculosis.

Honourable PM talking about Truenat as “Make in India” solution in the global conference on EndTB

March 13, 2018

Dr. Soumya Swaminathan
(Former Director General, ICMR) discusses about TrueNat

October 04, 2017

Nandan Nilekani makes a mention of Bigtec Labs in his book Imagining India: Ideas for the New Century

Excerpts from ICMR press release

The Truenat test is a novel, point-of-care, molecular test that is made in India, with chips for TB and a variety of diseases (e.g. malaria, dengue, HIV).
It is a multi-disease platform designed for decentralized settings (e.g. microscopy centres or Primary Health Centres) with demonstrated capability for linking results to online patient records, remote notification, remote usage monitoring, and the costs are expected to be lower than currently used imported tests.
Copy link
Powered by Social Snap